3009090-13-2
Chemical Structure
Anticancer agent 106
- CAS No.: 3009090-13-2
- Formula:C26H25N3O4S
- Molecular Weight:475.56
IUPAC Name: ethyl (E)-2-(5-amino-4-cyano-3-oxo-2-(2-oxo-2-(p-tolyl)ethylidene)-2,3-dihydro-1H-pyrrol-1-yl)-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophene-3-carboxylate
InChIKey: ROARVGHZVSZUAV-CPNJWEJPSA-N
SMILES: N#CC1=C(N)N(C2=C(C(OCC)=O)C(CCCCC3)=C3S2)/C(C1=O)=C/C(C4=CC=C(C)C=C4)=O
Biological Activity: Anticancer agent 106 (compound 10ic) is an anticancer agent that induces apoptosis in B16-F10 melanoma cells. Anticancer agent 106 also potently inhibits metastatic nodules in a mouse model of lung metastatic melanoma. Anticancer agent 106 can be used in the study of cancer, especially lung metastatic melanoma[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Anticancer agent 106 | Anticancer agent 106 (compound 10ic) is an anticancer agent that induces apoptosis in B16-F10 melanoma cells. Anticancer agent 106 also potently inhibits metastatic nodules in a mouse model of lung metastatic melanoma. Anticancer agent 106 can be used in the study of cancer, especially lung metastatic melanoma. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
